| Authors: |
Jonsson P; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bandlamudi C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheng ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Srinivasan P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chavan SS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Friedman ND; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Richards AL; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bouvier N; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Selcuklu SD; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bielski CM; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abida W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mandelker D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Birsoy O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baselga J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; AstraZeneca, Waltham, MA, USA., Offit K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scher HI; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stadler ZK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schultz N; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Socci ND; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Viale A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ladanyi M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Robson ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Berger MF; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.; Weill Cornell Medical College, New York, NY, USA. bergerm1@mskcc.org., Solit DB; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.; Weill Cornell Medical College, New York, NY, USA. solitd@mskcc.org., Taylor BS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.; Weill Cornell Medical College, New York, NY, USA. taylorb@mskcc.org. |
